DONATE
Credit card PayPal By phone
In memory In your Will
Home Menu Search
  • Research

    Research

    Garvan's medical research will transform healthcare. We explore the full spectrum of disease so that everyone can live longer and healthier lives. Read some of our key breakthroughs.

    • Diseases we research
    • Our researchers
    • Our faculty
    • Labs & groups
    • Clinical trials
    • Collaborative programs
    • Research centres
    • Research services
    • Business development & innovation

    Brain-icon.png

  • Support us

    Support us

    Help us unlock the secrets of disease. 

    Garvan gift cards available now!

    • Donate now
    • Donate in memory
    • Donate in celebration
    • A gift in your Will
    • Regular giving
    • Volunteer
    • Fundraise for us
    • Corporate giving
    • Workplace giving

    Donation Appeal.svg

  • News

    News

    Find our latest discoveries and scientific news, and meet some of our talented scientists.

    • Latest news
    • Breakthrough magazine
    • Sign up to eNews
    • Media enquiries

    Share.svg

     

  • Explore & learn

    Explore & learn

    Discover our science and take a tour of the Institute: hear about our breakthroughs, journey inside the body, and understand the latest in medical research.

    • Public tours
    • Virtual tours
    • Molecular animations
    • Public seminars
    • Researcher events
    • Genomics education
    • Free health guides

    Book a tour.png

     

  • Careers & studies

    Careers and studies

    Garvan is a world-class scientific institute. We are always looking for ambitious and inspiring people to work with us, please review the available positions and don’t hesitate to get in touch with any questions.

    • Career opportunities
    • Working for us
    • Postgraduate studies
    • Honours
    • Undergraduate

    Data.svg

  • About us

    About us

    The Garvan Institute of Medical Research has pioneered insights into some of the most widespread diseases affecting our community today. 
    Read about our history.

    • About the Garvan Institute
    • Leadership
    • Organisation structure
    • Our people
    • Our faculty
    • About the Garvan Research Foundation
    • Foundation leadership
    • Virtual tours
    • Annual Reports
    • Contact us
    • Ph 02 9295 8100

    Magnify.svg

  1. Home
Item type
New items since

Search results for mouse

568 items matching your search terms.
  1. Endogenous peptide YY and neuropeptide Y inhibit colonic ion transport, contractility and transit differentially via Y(1) and Y(2) receptors

    Background & purpose: Peptide YY (PYY) and neuropeptide Y (NPY) activate Y receptors, targets under consideration as treatments for diarrhoea and other ...

    Located in Research / Publications Search
  2. An Actn3 knockout mouse provides mechanistic insights into the association between alpha-actinin-3 deficiency and human athletic performance

    A common nonsense polymorphism (R577X) in the ACTN3 gene results in complete deficiency of the fast skeletal muscle fiber protein alpha-actinin-3 in an ...

    Located in Research / Publications Search
  3. Dr Daniel Suan Dr Daniel Suan

    Dan grew up in Perth and studied medicine at UWA before moving to Sydney to train as an Immunologist at Westmead Hospital and St Vincent's Hospital. After ...

    Located in About us / People
  4. Investigation of the role of prolactin in the development and function of the lacrimal and harderian glands using genetically modified mice

    PURPOSE: To determine whether prolactin receptor is essential for normal development and function of the lacrimal gland and whether hyperprolactinemia can ...

    Located in Research / Publications Search
  5. p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes

    While current thinking posits that insulin signaling to glucose transporter 4 (GLUT4) exocytic translocation and glucose uptake in skeletal muscle and ...

    Located in Research / Publications Search
  6. Insulin action under arrestin

    Insulin signaling is key to the etiology of metabolic syndrome. Recent work (Luan et al., 2009) uncovers a role for beta-arrestin, previously known to control ...

    Located in Research / Publications Search
  7. The influence of genetic background on the induction of oxidative stress and impaired insulin secretion in mouse islets

    AIMS/HYPOTHESIS: We determined whether high-glucose-induced beta cell dysfunction is associated with oxidative stress in the DBA/2 mouse, a mouse strain ...

    Located in Research / Publications Search
  8. Denisovan, modern human and mouse TNFAIP3 alleles tune A20 phosphorylation and immunity

    Resisting and tolerating microbes are alternative strategies to survive infection, but little is known about the evolutionary mechanisms controlling this ...

    Located in Research / … / CIRCA / CIRCA publications
  9. Elf5 is essential for early embryogenesis and mammary gland development during pregnancy and lactation

    Elf5 is an epithelial-specific ETS factor. Embryos with a null mutation in the Elf5 gene died before embryonic day 7.5, indicating that Elf5 is essential ...

    Located in Research / Publications Search
  10. Bidirectional GPR119 Agonism Requires Peptide YY and Glucose for Activity in Mouse and Human Colon Mucosa

    The lipid sensor G protein-coupled receptor 119 (GPR119) is highly expressed by enteroendocrine L-cells and pancreatic beta-cells that release the hormones, ...

    Located in Research / … / CIRCA / CIRCA publications
« Previous 10 items Next 10 items » 1 ... 7 8 9 10 11 12 13 ... 57

Latest news

Genetic and molecular insights into dangerous tick bite-related meat allergy revealed

Genetic and molecular insights into dangerous tick bite-related meat allergy revealed

05 July 2022
ACRF INCITe Centre for world-class cancer imaging launches at the Garvan Institute

ACRF INCITe Centre for world-class cancer imaging launches at the Garvan Institute

30 June 2022
Clinical trial to test potential new combination therapy for aggressive breast cancer

Clinical trial to test potential new combination therapy for aggressive breast cancer

21 June 2022
Refining the teaching tools by creating better scientific animations

Refining the teaching tools by creating better scientific animations

10 June 2022
More news

Subscribe to our mailing list for updates on our latest research and free public events:

Contact us

T. +61 (02) 9295 8100
F. +61 (02) 9295 8101
E. foundation@garvan.org.au

Supporter enquiries/donations

T. 1300 73 66 77

garvan location map

Locate us

384 Victoria Street
Darlinghurst NSW 2010 Australia

Services

  • Flow cytometry
  • Sequencing services
  • Garvan Molecular Genetics
  • Australian BioResources
  • More research services

Research centres

  • Garvan-Weizmann Centre for Cellular Genomics
  • Kinghorn Centre for Clinical Genomics
  • Centre for Targeted Therapy

News & publications

  • Latest news
  • Media enquiries
  • Breakthrough magazine
  • Scientific publications

Search

  • Staff search
  • Site search

Business development & innovation
Follow us:
  • Privacy policy
  • Sitemap
  • Accessibility
  • Intranet
  • Login
map of Australia

We acknowledge the Gadigal and Gundangara peoples, the traditional custodians of the lands on which the Garvan Institute and the ABR are located. We pay respects to Elders, past, present and future, and recognise their continuing connection and contribution to this land.

Garvan is committed to ensuring equity, diversity, inclusion and belonging are in our DNA and we are proud of what we can achieve when our people can come together.

acnc registered charity logo

The Garvan Institute of Medical Research (ABN 62 330 391 937) and the Garvan Research Foundation (ABN 91 042 722 738) are registered charities.

Affiliated with:

St Vincent Health Australia logo UNSW logo

© Garvan Institute 2021

Joint facility:

The Kinghorn Cancer Center logo